ReShape Medical, Inc. is a medical device company focused on the development and commercialization of its dual intragastric balloon for weight loss. Driven by a passion to address the worldwide obesity epidemic, the company has developed a non-surgical alternative for obese patients seeking treatment. Additional company information can be found at www.ReShapeReady.com. The ReShape Procedure has been available in the European Union since December 2011.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 08/26/15 | $38,000,000 | Series D |
Endeavour Vision Healthcor Partners New Leaf Venture Partners US Venture Partners Venture Investors | undisclosed |
